Numinus Wellness Inc. (NUMIF) Q4 2022 Earnings Call Transcript

Nov. 29, 2022 9:18 PM ETNuminus Wellness Inc. (NUMIF), NUMI:CA
SA Transcripts profile picture
SA Transcripts

Numinus Wellness Inc. (OTCQX:NUMIF) Q4 2022 Results Conference Call November 29, 2022 5:30 PM ET

Company Participants

Jamie Kokoska - Vice President, Investor Relations

Payton Nyquvest - Founder and Chief Executive Officer

John Fong - Chief Financial Officer

Reid Robison - Chief Clinical Officer

Paul Thielking - Chief Science Officer

Conference Call Participants

Michael Okunewitch - Maxim Group

Sepehr Manochehry - Eight Capital

Robert Sassoon - Water Tower Research


Good afternoon, and welcome to Numinus Wellness Inc.'s Fiscal Fourth Quarter and Annual 2022 Results Conference Call. A question-and-answer session for analysts and institutional investors will follow the formal remarks. As a reminder, this call is being recorded.

I would now like to turn the conference call over to your host, Jamie Kokoska, Vice President of Investor Relations. Please proceed.

Jamie Kokoska

Thank you, Brent. Good afternoon, everyone, and thank you for joining us for our fiscal fourth quarter and annual 2022 results conference call. Discussing Numinus' performance today are Payton Nyquvest, Founder and CEO; and John Fong, Chief Financial Officer. Joining them for analyst questions at the end of our formal remarks are Reid Robison, Chief Clinical Officer; and Paul Thielking, Chief Science Officer.

The following discussion may include forward-looking statements that are based on current expectations and are subject to a number of risks and uncertainties. The risks and uncertainties that could cause our actual financial and operating results to differ significantly from our forward-looking statements are detailed in our MD&A for the quarter and the year ended August 31, 2022, and in our other Canadian securities filings available on SEDAR. Numinus does not undertake to update or revise any forward-looking statements to reflect new events or circumstances, except as required by law. Our fourth quarter results were made available earlier this afternoon. We encourage you to review our earnings release, MD&A and financial statements, which are

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.